FOS and central nervous system cancer: In the present study, we compared FOS promoter activity with four tumor-specific promoters in human glioma cell lines and astrocytes, and tested the biologic activity of recombinant adenovirus containing suicide genes driven by FOS promoter, including selective killing efficacy in vitro and tumor inhibition rate in vivo.